Iterative Scopes, provider of precision medicine technologies for gastroenterology, has entered into a data sharing agreement with Pfizer to accelerate the development of potential new treatments for patients suffering from IBD by standardising endoscopic interpretation. Context Currently, disease severity scoring systems, such as the Mayo Endoscopic… Read More
Thermo Fisher Scientific has launched a new automated sample transfer system that can process 192 saliva or nasopharyngeal samples from tube to well in 40 minutes to address a pain point and accelerate sample processing workflow. The ‘pain point’ Scientific research in areas such as… Read More
Researchers from National Institute of Standards and Technology (NIST), Baylor College of Medicine and DNAnexus, together with other members of the Genome in a Bottle (GIAB) consortium, have announced the publication of a comprehensive benchmark dataset comprising 273 challenging medically-relevant autosomal genes that are associated with the development of… Read More
Angelini Pharma has announced that cenobamate, an oral anti-seizure medicine (ASM), is now available for use within NHS Scotland as a treatment for eligible adults with uncontrolled focal epilepsy. The Scottish Medicines Consortium (SMC) has accepted cenobamate for restricted use in adults with drug-resistant epilepsy as a second-line adjunctive… Read More
Researchers at the Francis Crick Institute and King’s College London have identified how specialist immune cells, called gamma delta T cells (γδ T cells), sense the body’s status quo, enabling them to assess the health of surface tissues and even protect against cancer-causing DNA damage. Context … Read More
The Cambridge Crystallographic Data Centre (CCDC) has entered a strategic partnership with Dassault Systèmes to advance bioscience innovation with a cloud-based virtual screening solution. The collaboration The collaboration integrates GOLD — CCDC’s protein-ligand docking software for drug discovery — with Dassault Systèmes’ BIOVIA therapeutics design… Read More
As the global Covid-19 pandemic enters its third year, the life sciences innovation system is setting new records in the level of investment, activity, and scientific progress, according to the IQVIA Institute. In its report, Global Trends in R&D: Overview through 2021, the IQVIA assesses the trends in new drug… Read More
Researchers from the Universities of Bristol and Hamburg have engineered bacteria with internal nutrient reserves that can be accessed when needed to survive extreme environmental conditions. The findings pave the way for more robust biotechnologies based on engineered microbes. The challenge Dr Thomas Gorochowski, joint… Read More
PerkinElmer’s SIRION Biotech business and the Centre for Genomic Regulation (CRG) have agreed to jointly develop new generation adeno-associated virus (AAV) vectors for Type 1 and Type 2 diabetes gene therapy in the pancreas. The collaboration The collaboration combines SIRION’s AAV technology platform and expertise… Read More
BioIVT will be hosting an open house from 19:00-21:00PM on February 23, 2022 at the Scale Space venue in London, where researchers can see how the company’s biospecimens are collected and processed. Context BioIVT is hosting this event to celebrate its partnership with One Nucleus,… Read More
The National Institute for Health and Care Excellence (NICE) in the UK has issued a Final Appraisal Document (FAD) recommending AstraZeneca’s Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults with chronic kidney disease (CKD).1 Conditions Dapagliflozin is recommended as an option… Read More
Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally. Moving forward As the world looks to improve public health now and after the… Read More
eTheRNA immunotherapies has partnered with Merck to investigate the application of eTheRNA’s mRNA design expertise and LNP-delivery platforms to disease areas selected by Merck. Context The ongoing pandemic has underlined the capability for mRNA vaccines as a new therapeutic modality. eTheRNA and Merck both recognise… Read More
Antiverse has partnered with a top 20 pharma company and has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods. The sequencing Using Antiverse’s AI-Augmented Drug Discovery platform, 248 sequences… Read More
DDW's Megan Thomas looks at three regions and their approach to digitalisation. 1. United Kingdom A report published by the Association of the British Pharmaceutical Industry (ABPI) has identified the skills and training conditions needed for the future success of UK life sciences. George Freeman, Minister for Science, Research, and… Read More
The cell and gene therapy (CGT) industry is booming, say Sergio Lainez Vicente (Senior Manager of Business Operations in the Cell & Gene Therapy / Large Molecule area) and Jaleel Shujath (Vice President of Marketing and Content), at Absorption Systems, a Pharmaron company. Around 1200 potential cell and gene therapies… Read More
